Zentalis Pharmaceuticals ZNTL
NASDAQ ZNTL
$2.74 +0.03 (+1.10%)
As of: Sep 30, 2026 · 11:55 AM EDT

Zentalis Pharmaceuticals (ZNTL) Receivables (2019 - 2024)

Updated

Zentalis Pharmaceuticals' Receivables came in at $5 million for Q4 2024.

Analysis

Zentalis Pharmaceuticals (ZNTL) Receivables (2019 - 2024) Analysis & Trends

Going back to Q4 2019, Zentalis Pharmaceuticals' Receivables data covers 10 quarters.

  • Receivables carries a five-year compound annual growth rate of 71.2% (FY2019 to FY2024).
  • Going back by year, Receivables was $2.38 million in FY2021 (-89.4%) and $22.42 million in FY2020.
  • The Q4 2024 figure represents the highest quarterly Receivables since Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Zentalis Pharmaceuticals 186.34 Mn 186.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5.00 Mn
Dec 31, 2021 2.38 Mn
Sep 30, 2021 3.05 Mn
Jun 30, 2021 5,000.00
Mar 31, 2021 31.25 Mn
Dec 31, 2020 417,000.00
Sep 30, 2020 222,000.00
Jun 30, 2020 173,000.00
Mar 31, 2020 82.14 Mn
Dec 31, 2019 340,000.00
API Access

Zentalis Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ZNTL&period=max&api_key=YOUR_API_KEY